Open | - |
Close | - |
Volume / Avg. | 0 / 2.158M |
Day Range | - - - |
52 Wk Range | 3.740 - 18.305 |
Market Cap | $2.722B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 71 |
Short Interest | % |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of MorphoSys (NASDAQ: MOR) through any online brokerage.
Other companies in MorphoSys’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX), TG Therapeutics (NASDAQ:TGTX) and PTC Therapeutics (NASDAQ:PTCT).
The latest price target for MorphoSys (NASDAQ: MOR) was reported by Wells Fargo on Thursday, March 14, 2024. The analyst firm set a price target for 18.25 expecting MOR to rise to within 12 months (a possible 0.83% upside). 13 analyst firms have reported ratings in the last year.
The stock price for MorphoSys (NASDAQ: MOR) is $18.1 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for MorphoSys.
MorphoSys’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for MorphoSys.
MorphoSys is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.